Health
CanSino to start Phase III trial of COVID-19 vaccine in Saudi – Marketscreener.com
Saudi Arabia will soon begin Phase
III clinical trials on around 5,000 people for a COVID-19
vaccine developed by China’s CanSino Biologics Inc, a
Saudi health ministry spokesman said on Sunday.
… | August 9, 2020
DUBAI, Aug 9 (Reuters) – Saudi Arabia will soon begin Phase
III clinical trials on around 5,000 people for a COVID-19
vaccine developed by China’s CanSino Biologics Inc, a
Saudi health ministry spokesman said on Sunday.
Last month, CanSino’s co-founder said the company was in
talks with Russia, Brazil, Chile and Saudi Arabia to launch a
Phase III trial of the vaccine candidate, Ad5-nCOV.
The vaccine uses a harmless cold virus known as adenovirus
type-5 (Ad5) to carry genetic material fro…
-
General22 hours agoMourners arrive for Diogo Jota’s wake in Liverpool forward’s hometown in Portugal
-
Business22 hours ago3 ASX growth shares to buy before the next bull market
-
General8 hours agoMatildas vs Panama international friendly — live blog and scores from Bunbury
-
General22 hours agoDear God! It’s 2028 | The Spectator Australia